Insider Transactions in Q2 2021 at Chinook Therapeutics, Inc. (KDNY)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2021
|
Alan Glicklich Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-100.0%
|
$320,000
$16.35 P/Share
|
|
Jun 16
2021
|
Alan Glicklich Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$0
$0.42 P/Share
|
|
Jun 14
2021
|
Eric Dobmeier President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+16.97%
|
$0
$0.35 P/Share
|
|
May 14
2021
|
Eric Dobmeier President, CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+1.27%
|
$14,000
$14.44 P/Share
|